Interesting discussions and talks at this years' "AgnostiC Tumor In ONcology-ACTION" in Malaga. A need for new trial designs, testing challenges, access to new drugs and health economy, update from the protarget study to mention some talks.
MATRIX @ElenaGarralda Hege Russnes